首页 | 本学科首页   官方微博 | 高级检索  
     

国产治疗用卡介苗预防浅表性膀胱癌术后复发及不良反应的观察
引用本文:黄建,王国治,许纯兰,金杰.国产治疗用卡介苗预防浅表性膀胱癌术后复发及不良反应的观察[J].粉末涂料与涂装,2010,23(4).
作者姓名:黄建  王国治  许纯兰  金杰
作者单位:黄建,王国治,许纯兰(中国药品生物制品检定所菌苗室,北京,100050);金杰(北京医科大学泌尿外科研究所,北京,100034) 
摘    要:目的观察我国治疗用卡介苗(CT-BCG)预防浅表性膀胱癌术后复发情况及其不良反应。方法对117例浅表性膀胱癌患者术后给予CT-BCG治疗,另对53例患者采用丝裂霉素C(MI-C)治疗,作为对照。CT-BCG组每次用药120mg,MI-C组40mg。用导管灌注膀胱,2h后自行排出。术后2或3周开始,不同时间用药1次,直至1年。观察两组的复发情况及不良反应发生率。结果CT-BCG组复发率为18.8%,MI-C组为13.2%,二者差异无统计学意义;不良反应主要为膀胱炎症状(尿痛、尿频、血尿等)及低热,MI-C组无低热患者,且膀胱炎症状也较CT-BCG组轻。结论CT-BCG预防浅表性膀胱癌术后复发药效良好,无严重不良反应发生。

关 键 词:治疗用卡介苗  浅表性膀胱癌  复发  不良反应

Clinical Trial of Effect and Adverse Reaction of Domestic Therapeutic BCG for Prevention of Recurrence of Superficial Bladder Cancer
HUANG Jian,WANG Guo-zhi,XU Chun-lan,et al.Clinical Trial of Effect and Adverse Reaction of Domestic Therapeutic BCG for Prevention of Recurrence of Superficial Bladder Cancer[J].Chinese Journal of Biologicals,2010,23(4).
Authors:HUANG Jian  WANG Guo-zhi  XU Chun-lan  
Affiliation:HUANG Jian,WANG Guo-zhi,XU Chun-lan,et al (National Institute for the Control of Pharmaceutical , Biological Products,Beijing 100050,China)
Abstract:Objective To observe the effect and adverse reaction of domestic therapeutic BCG, i.e. Chinese therapeutic BCG (CT-BCG)for prevention of recurrence of superficial bladder cancer. Methods A total of 117 patients with superficial bladder cancer after surgery were treated with 120 mg of CT-BCG, using 53 patients treated with 40 mg of milomycin-c (MI-C)as control. The CT-BCG and MI-C were infused into bladder through a vessel and excreted by the patients themselves 2 h later. The drugs were administered 2 or 3 ...
Keywords:Therapeutic BCG  Superficial bladder cancer  Recurrence  Adverse reaction
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号